MAY 29, 2014 09:00 AM PDT

Keynote Panel Discussion: Companion Diagnostics: Changing the Face of Healthcare, Doctors Hawkins, Joseph, and Frank

82 42 3087

  • Patrick Joseph, MD, Medical Director, Siemens Clinical Laboratory (SCL), Siemens Healthcare Diagnostics Richard Frank, MD, Chief Medical Officer, Clinical Strategy and Policy, Siemens Health

      Dr. Richard Frank, MD 
      Dr. Richard Frank is Chief Medical Officer, Clinical Strategy and Policy, for Siemens Healthcare. With over 30 years global experience in the design, regulatory labeling, public and private payment for, and clinical adoption of therapeutic and diagnostic drugs and devices, Dr. Frank offers a broad, real-world perspective on the evolving role of diagnostics in todays healthcare marketplace. Dr. Franks similarly global experience with government agencies and non-governmental organizations (NGOs), and within both academia and industry, gives him particular expertise in clinical evidentiary standards, government policy, and the product-, market-, and delivery system-specific inefficiencies and issues that burden payers and delay or skew patients access to the benefits of innovation. 
      Dr. Patrick Joseph, MD
      Dr. Patrick Joseph serves as Medical Director for the Siemens Clinical Laboratory (SCL) of Siemens Healthcare Diagnostics in Berkeley, California. A distinguished infectious-disease specialist and epidemiologist, Dr. Joseph is an appointed Fellow of the Infectious Disease Society of America and the Society of Healthcare Epidemiologists of America. Dr. Joseph completed his specialty training in internal medicine, infectious disease, and laboratory medicine at the University of California, San Francisco, where he is currently Associate Clinical Professor of Medicine. Since 1983, he has practiced clinical medicine and held laboratory director roles for commercial and research laboratories that employ both conventional and novel molecular diagnostic techniques. He currently holds medical staff appointments with Highland Alameda County Medical Center, San Ramon Regional Medical Center, and Alta-Bates Summit Medical Center in Berkeley, California. 


    What is the future of personalized medicine? Featuring Dr. Trevor Hawkins (An Introduction to Companion Diagnostics), Dr. Patrick Joseph (Making It Personal for Patients), and Dr. Richard Frank (The Impact on Healthcare Policy), this lively panel discussion will highlight the many ways in which Companion Diagnostics are changing the face of healthcare.
    As a patient-centric shift continues to sweep our healthcare system, pharmaceutical companies are increasingly seeing the value of targeting treatments to specific patient populations, making their therapies more personal. In the burgeoning age of personalized medicine, companies are looking for ways to develop more specific, efficacious, and cost-effective treatments that are tailored to a patients needs, rather than focusing solely on the blockbuster drugs that have dominated the industry over the past few decades. Some companies have found novel ways to accommodate this shift, including adjusting their business models to focus on healthcare outcomes and collaborating with payers and providers to simplify reimbursement and provide tools and technologies to increase medication adherence.
    Join Drs. Hawkins, Joseph, and Frank and learn how companion diagnostics promises to change the way patients are treated, therapies may be prescribed, and tests are developed, and how this fast-moving evolution will impact all of healthcare.

    Learning Objectives:

    At the end of the presentation, attendees will be able to:

    • Understand how companion diagnostics may improve patient outcomes by personalizing medicine.
    • Appreciate the pathways for adoption and prescription of companion diagnostic tests.

    Show Resources
    Loading Comments...